SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-23-022731 from NovelStem International Corp. (NSTM) (CIK 0000912544) (NSTM)

NovelStem International Corp. (NSTM) (CIK 0000912544)
Date: June 28, 2023 · CIK: 0000912544 · Accession: 0001493152-23-022731

AI Filing Summary & Sentiment

File numbers found in text: 000-22908

Referenced dates: March 2, 2023, May 17, 2023

Date
June 26, 2023
Author
President
Form
CORRESP
Company
NovelStem International Corp. (NSTM) (CIK 0000912544)

Letter

NovelStem International Corp.

Glades Road Suite 221A

Boca Raton, Florida 33431

June 28, 2023

VIA EDGAR

Securities and Exchange Commission

F Street, N.E.

Washington, DC 20549-7010

Re: NovelStem International Corp.

Amendment No. 4 to Registration Statement on Form 10-12G

Correspondence Filed June 26, 2023

File No. 000-22908

Ladies and Gentlemen:

The following responses address the comments of the reviewing Staff of the Commission as set forth in the Staff’s comment letter dated May 17, 2023, relating to the registration statement on Form 10-12G, as amended (the “Registration Statement”), of NovelStem International Corp. (the “Company” or “NovelStem”). For ease of reference, we have included the prior comment on which supplemental information was requested by the Staff:

1. Amendment No. 3 to Registration Statement on Form 10-12G

General

We note your response to comment 1 of our letter dated March 2, 2023 and reissue in part. Given that your ability to rely on Rule 3a-1 under the Investment Company Act will depend (among other things) on facts and circumstances regarding your control of NewStem, and that you retain significant investment company status risk, please enhance your investment company status risk disclosure to indicate that you intend to rely on Rule 3a-1 under the Investment Company Act and explain the basis for such reliance.

Response:

The Staff’s most recent comment seeks enhanced investment company status risk disclosure in the Registration Statement. In response to the Staff’s comment, we have amended the Registration Statement to include the following risk disclosure:

We may be deemed an investment company, which could impose on us burdensome compliance requirements.

The Investment Company Act of 1940, as amended (the “Investment Company Act”), requires companies to register as an investment company if they are engaged primarily in the business of investing, reinvesting, owning, holding, or trading securities. Section 3(a)(1)(A) of the Investment Company Act defines an investment company as any issuer that is or holds itself out as being engaged primarily in the business of investing, reinvesting or trading in securities. In addition, Section 3(a)(1)(C) of the Investment Company Act defines an investment company as any issuer that is engaged or proposes to engage in the business of investing, reinvesting, owning, holding or trading in securities and owns or proposes to acquire investment securities having a value exceeding 40% of the value of the issuer’s total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. We are not in the business of investing, reinvesting, owning, holding or trading securities and we do not believe that we would meet the definition of an “investment company” under the Investment Company Act, as further discussed below.

NovelStem International Corp.

June 28, 2023

Page

We trust that the foregoing appropriately addresses the comment raised by the Staff’s May 17 comment letter. Thank you in advance for your prompt review and assistance.

Very
truly yours,
/s/
Jan Loeb

Show Raw Text
CORRESP
1
filename1.htm

NovelStem
International Corp.

2255
Glades Road Suite 221A

Boca
Raton, Florida 33431

June
28, 2023

VIA
EDGAR

Securities
and Exchange Commission

100
F Street, N.E.

Washington,
DC 20549-7010

    Re:
    NovelStem
    International Corp.

    Amendment
    No. 4 to Registration Statement on Form 10-12G

    Correspondence
    Filed June 26, 2023

    File
    No. 000-22908

Ladies
and Gentlemen:

The
following responses address the comments of the reviewing Staff of the Commission as set forth in the Staff’s comment letter dated
May 17, 2023, relating to the registration statement on Form 10-12G, as amended (the “Registration Statement”), of NovelStem
International Corp. (the “Company” or “NovelStem”). For ease of reference, we have included the prior comment
on which supplemental information was requested by the Staff:

    1.
    Amendment
    No. 3 to Registration Statement on Form 10-12G

    General

    We
    note your response to comment 1 of our letter dated March 2, 2023 and reissue in part. Given that your ability to rely on Rule 3a-1
    under the Investment Company Act will depend (among other things) on facts and circumstances regarding your control of NewStem, and
    that you retain significant investment company status risk, please enhance your investment company status risk disclosure to
    indicate that you intend to rely on Rule 3a-1 under the Investment Company Act and explain the basis for such
    reliance.

Response:

The
Staff’s most recent comment seeks enhanced investment company status risk disclosure in the Registration Statement. In response
to the Staff’s comment, we have amended the Registration Statement to include the following risk disclosure:

We
may be deemed an investment company, which could impose on us burdensome compliance requirements.

The
Investment Company Act of 1940, as amended (the “Investment Company Act”), requires companies to register as an investment
company if they are engaged primarily in the business of investing, reinvesting, owning, holding, or trading securities. Section 3(a)(1)(A)
of the Investment Company Act defines an investment company as any issuer that is or holds itself out as being engaged primarily in the
business of investing, reinvesting or trading in securities. In addition, Section 3(a)(1)(C) of the Investment Company Act defines an
investment company as any issuer that is engaged or proposes to engage in the business of investing, reinvesting, owning, holding or
trading in securities and owns or proposes to acquire investment securities having a value exceeding 40% of the value of the issuer’s
total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. We are not in the business of investing,
reinvesting, owning, holding or trading securities and we do not believe that we would meet the definition of an “investment company”
under the Investment Company Act, as further discussed below.

NovelStem
International Corp.

June
28, 2023

Page
2

We
trust that the foregoing appropriately addresses the comment raised by the Staff’s May 17 comment letter. Thank you in advance
for your prompt review and assistance.

    Very
    truly yours,

    /s/
    Jan Loeb

    Jan
    Loeb

    President
    and Executive Chairman